SURVIVAL IMPACT OF SKELETAL METASTASIS ON BONE SCINTIGRAPHY IN PATIENTS WITH GERM CELL TUMOURS
Abstract
Objective: Our aim was to determine the frequency of skeletal metastasis in germ cell tumours (GCT) at baseline and relapse on conventional technetium-99m methylene diphosphonate (Tc-99m MDP) whole body bone scan (bone scan) and to evaluate the effect of bone metastases on survival.
Materials and Methods: Electronic medical records of histologically proven GCT over 64 months were retrospectively analysed. Basic demographic and histologic information were correlated with the presence of osseous and visceral metastases. 5-year disease-free survival (DFS) and overall survival (OS) were calculated in presence, the absence of bone metastases at baseline and at relapse.
Results: A total of 130 gonadal and extragonadal GCT patients underwent Tc-99m MDP bone scans; four with insuf cient data were excluded from the study. 47% were females and 53% were males with the age range of 1 month – 72 years. 105 (83%) were under 18 years of age. Osseous metastasis was detected in 12 (9.5%). Two (17%) had solitary and 10 (83%) had multifocal skeletal metastases. Clinically, 83% had localised bone pain. Osseous metastases were more frequently associated with mixed GCT and yolk sac tumour. 50% of mediastinal GCT developed bone metastases. 42% died within 4–18 months. There was a statistically signi cant impact of visceral metastases on DFS and OS. OS at 5 years in patients without bone metastases, with bone metastases at baseline and bone metastases at relapse, was 77%, 38% and 75%, respectively. 5-year DFS for the same cohort groups was 63%, 38% and 20%, respectively.
Conclusion: Osseous involvement was found in 9.5% of GCT patients undergoing diagnostic Tc-99m MDP bone scan. Baseline skeletal evaluation for metastases should be done, particularly in the case of bone pains or known systemic metastases. Although skeletal relapses are rare, they have a grim outcome.
Key words: Bone scintigraphy, germ cell tumours, skeletal metastases
References
Riese MJ, Vaughn DJ. Chemotherapy for patients with poor prognosis germ cell tumors. World J Urol 2009;27:471-6.
Jamal-Hanjani M, Karpathakis A, Kwan A, et al. Bone metastases in germ cell tumours: Lessons learnt from a large retrospective study. BJU Int 2013;112:176-81.
International germ cell consensus classi cation: A prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol 1997;15:594-603.
Samanta DR, Bose C, Krishnappa R, et al. Mixed germ cell tumor of testis with isolated scapular metastasis: A case report and
review of the literature. Case Rep Urol 2015; 2015:205297.
Hitchins RN, Philip PA, Wignall B, et al. Bone disease in testicular and extragonadal germ cell tumours. Br J Cancer 1988; 58:793-6.
Vaughn DJ, Stadtmauer EA. Poor-prognosis germ cell tumors: We have not yet crossed the nish line. J Clin Oncol 2007; 25:239 40.
Grommes C, Bosl GJ, DeAngelis LM. Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy. Cancer 2011;117:1911-6.
Cantwell BM, Mannix KA, Harris AL. Back pain-a presentation of metastatic testicular germ cell tumours. Lancet 1987;1:262-4.
Oechsle K, Bokemeyer C, Kollmannsberger C, et al. Bone metastases in germ cell tumor patients. J Cancer Res Clin Oncol 2012;138:947-52.
Bokemeyer C, Nichols CR, Droz JP, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis. J Clin Oncol 2002;20:1864-73.
Mead GM, Stenning SP, Parkinson MC, et al. The second medical research council study of prognostic factors in nonseminomatous germ cell tumors. Medical research council testicular tumour working party. J Clin Oncol 1992; 10:85-94.
Asthana AK, Singh OP, Pant GC, et al. Seminoma of testis with unusual bone metastasis. Br J Urol 1988;62:380-1.
Benedetti G, Rastelli F, Fedele M, et al. Presentation of nonseminomatous germ cell tumor of the testis with symptomatic solitary bone metastasis. A case report with review of the literature. Tumori 2006;92:433-6.
Uygun K, Karagol H, Kocak Z, et al. Isolated bone metastasis in testicular germ cell tumors: A case report and review of the literature. Onkologie 2006;29:93-5.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.
